CPME Rapporteur on Pharmacovigilance: Dr Christiaan KEIJZER and Dr Erszébet PODMANICZKY

CPME Secretariat : Ms Carole ROUAUD

CPME has been working on the issue of safety of medicines for many years.  The revision of the Pharmacovigilance legislation has been agreed at European level in December 2010, the aim being to improve the safety of medicines at European level, mainly by strengthening the role of the European Medicines Agency (EMA) with regard to scientific evaluation and control of medicines, as well as on effective signal detection mechanisms when a medicine presents a risk to patients’ safety. CPME currently monitors the policy developments in this field.

Adopted policies include: